Lakeshore Biopharma CO (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -24,308 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 2,776 | N/A | N/A |
| Income taxes - deferred | N/A | N/A | -114 | N/A | N/A |
| Accounts receivable | N/A | N/A | 3,947 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 632 | N/A | N/A |
| Other Working Capital | N/A | N/A | -285 | N/A | N/A |
| Other Operating Activity | 0 | 0 | -2,961 | 0 | 0 |
| Operating Cash Flow | $N/A | $N/A | $-20,311 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -3,262 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-3,262 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 28,025 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -21,777 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $6,248 | $N/A | $N/A |
| Exchange Rate Effect | N/A | N/A | 1,941 | N/A | N/A |
| Beginning Cash Position | N/A | N/A | 51,585 | N/A | N/A |
| End Cash Position | N/A | N/A | 36,200 | N/A | N/A |
| Net Cash Flow | $N/A | $N/A | $-15,385 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -20,311 | N/A | N/A |
| Capital Expenditure | N/A | N/A | -3,284 | N/A | N/A |
| Free Cash Flow | 0 | 0 | -23,595 | 0 | 0 |